ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
The Pharmaceutical Company Licenses in Two New Drugs for Dry Eye Disease with over 200 Million US Dollars
August 25, 2021On August 5, Oyster Point Pharma, Inc. revealed on its official website that it has reached a cooperation agreement with Ji Xing Pharmaceuticals, which will develop and commercialize OC-01 (varenicline) and OC-02 (simpinicline) nasal sprays for patients. -
Oyster Point Pharma Announces New Chairperson Appointment to Board of Directors
August 03, 2021Oyster Point Pharma, Inc. (Nasdaq: OYST) today announced the appointment of a new Director and Chairperson to its Board of Directors. -
Oyster Point raises $93m in financing round to fund DED pipeline
February 28, 2019Princeton-based clinical stage pharma company Oyster Point has announced it has raised $93m in a Series B funding round. The investment will be used to support the development of its Dry Eye Disease (DED) portfolio....
Pharma Sources Insight January 2025
